|
| |
|
Table |
|
Hyperzincaemia and
Hypercalprotectinaemia: A New Disorder of Zinc Metabolism |
|
Volume 19,
Issue 2, 2003 |
|
|
|
|
Table - Clinical and Laboratory Data of Patients |
| |
|
|
Patient 1 |
Patient 2 |
Patient 3 |
Patient 4 |
Patient 5 |
|
Age (years) |
18 |
9 |
14 |
35 |
21 |
|
Sex |
M |
F |
M |
F |
M |
|
Growth failure |
<3rd percentile |
<3rd percentile |
<3rd percentile |
Normal |
Normal |
|
Hepatosplenomegaly |
Yes |
Yes |
Yes |
Yes |
Yes |
|
Dermatological
symptoms |
Vasculitis |
None |
None |
Vasculitis,
eczema |
Vasculitis,
furuncules ulcers |
|
Rheumatic
symptoms |
Arthritis |
Arthritis |
Arthritis |
Arthritis,
uveitis |
Arthritis |
|
Plasma
C-reactive protein (mg/L)† |
41-143 |
100-200 |
22 |
17 |
45-146 |
|
Haemoglobin
(g/L) |
80 |
90 |
109 |
125 |
80 |
|
Total white-cell
counts
(109
cells/mL) |
2-0 |
3.7-5.0 |
1.5 |
5.0 |
3.8 |
|
Monocytes |
0 |
|
1.9% |
1.9% |
4.3% |
|
Plasma zinc (
mol/L)‡ |
180-200 |
82-96 |
160-200 |
175 |
77 |
|
Plasma
calprotectin (g/L)§ |
6.5 |
1.4, 2.55 |
9 |
6.1 |
1.5 |
|
|
|
|
†Reference <10 mg/L.
‡Reference 10-18 mol/L. §Reference <1 mg/L |
| |
| Adapted from
Sampson B, et al.
Lancet 2002;360:1742-1745. |
| |
|
Back to article |
| |
|
|
|
|
|
|
|
|
|
|
